Huang Tsui-Chin, Lee Pin-Tse, Wu Ming-Heng, Huang Chi-Chen, Ko Chiung-Yuan, Lee Yi-Chao, Lin Ding-Yen, Cheng Ya-Wen, Lee Kuen-Haur
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Cellular Pathobiology Section, Intramural Research Program, National Institute on Drug Abuse, Rockville, Maryland, United States of America.
PLoS One. 2017 Aug 31;12(8):e0181034. doi: 10.1371/journal.pone.0181034. eCollection 2017.
The canonical Wnt/β-catenin pathway is constitutively activated in more than 90% of colorectal cancer (CRC) cases in which β-catenin contributes to CRC cell growth and survival. In contrast to the Wnt/β-catenin pathway, the non-canonical Wnt pathway can antagonize functions of the canonical Wnt/β-catenin pathway. Wnt5a is a key factor in the non-canonical Wnt pathway, and it plays diverse roles in different types of cancers. It was shown that reintroducing Wnt5a into CRC cells resulted in inhibited cell proliferation and impaired cell motility. However, contradictory results were reported describing increased Wnt5a expression being associated with a poor prognosis of CRC patients. Recently, it was shown that the diverse roles of Wnt5a are due to two distinct roles of Wnt5a isoforms. However, the exact roles and functions of the Wnt5a isoforms in CRC remain largely unclear. The present study for the first time showed the ambiguous role of Wnt5a in CRC was due to the encoding of distinct roles of the various Wnt5a mRNA isoforms. A relatively high expression level of the Wnt5a-short (S) isoform transcript and a low expression level of the Wnt5a-long (L) isoform transcript were detected in CRC cell lines and specimens. In addition, high expression levels of the Wnt5a-S mRNA isoform and low expression levels of the Wnt5a-L mRNA isoform were significantly positively correlated with tumor depth of CRC patients. Furthermore, knockdown of the endogenous expression of the Wnt5a-S mRNA isoform in HCT116 cells drastically inhibited their growth ability by inducing apoptosis through induction of FASLG expression and reduction of TNFRSF11B expression. Moreover, reactivation of methylation inactivation of the Wnt5a-L mRNA isoform by treatment with 5-azacytidine (5-Aza) enhanced the siWnt5a-S isoform's ability to induce apoptosis. Finally, we showed that the simultaneous reactivation of Wnt5a-L mRNA isoform and knockdown of Wnt5a-S mRNA isoform expression enhanced siWnt5a-S isoform-induced apoptosis and siWnt5a-L isoform-regulated suppression of β-catenin expression in vitro. High expression levels of the Wnt5a-S mRNA isoform and low expression levels of the Wnt5a-L mRNA isoform were significantly positively correlated with high mRNA levels of β-catenin detection in vivo. Altogether, our study showed that, for the first time, different Wnt5a mRNA isoforms play distinct roles in CRC and can be used as novel prognostic markers for CRC in the future.
在90%以上的结直肠癌(CRC)病例中,经典Wnt/β-连环蛋白信号通路被组成性激活,其中β-连环蛋白有助于CRC细胞的生长和存活。与Wnt/β-连环蛋白信号通路相反,非经典Wnt信号通路可以拮抗经典Wnt/β-连环蛋白信号通路的功能。Wnt5a是非经典Wnt信号通路中的关键因子,它在不同类型的癌症中发挥着多种作用。研究表明,将Wnt5a重新引入CRC细胞会导致细胞增殖受到抑制和细胞运动能力受损。然而,也有报道称Wnt5a表达增加与CRC患者的不良预后相关,这一结果相互矛盾。最近的研究表明,Wnt5a的多种作用归因于Wnt5a异构体的两种不同作用。然而,Wnt5a异构体在CRC中的确切作用和功能仍不清楚。本研究首次表明,Wnt5a在CRC中的作用不明确是由于各种Wnt5a mRNA异构体编码了不同的作用。在CRC细胞系和标本中检测到Wnt5a短(S)异构体转录本的表达水平相对较高,而Wnt5a长(L)异构体转录本的表达水平较低。此外,Wnt5a-S mRNA异构体的高表达水平和Wnt5a-L mRNA异构体的低表达水平与CRC患者的肿瘤深度显著正相关。此外,在HCT116细胞中敲低Wnt5a-S mRNA异构体的内源性表达,通过诱导FASLG表达和降低TNFRSF11B表达诱导细胞凋亡,从而显著抑制其生长能力。此外,用氮杂胞苷(5-Aza)处理重新激活Wnt5a-L mRNA异构体的甲基化失活,增强了siWnt5a-S异构体诱导细胞凋亡的能力。最后,我们表明,同时重新激活Wnt5a-L mRNA异构体和敲低Wnt5a-S mRNA异构体表达,可增强siWnt5a-S异构体诱导的细胞凋亡和siWnt5a-L异构体在体外对β-连环蛋白表达的调节抑制作用。Wnt5a-S mRNA异构体的高表达水平和Wnt5a-L mRNA异构体的低表达水平与体内β-连环蛋白检测的高mRNA水平显著正相关。总之,我们的研究首次表明,不同的Wnt5a mRNA异构体在CRC中发挥着不同的作用,未来可作为CRC新的预后标志物。